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Introduction
I t is widely accepted that maternal mortality is a proxy for maternal health status. Reducing maternal mortality to one 
fourth of its level in 1990 is one of the millennium develop-
ment goals for 2015, which shows its importance not only as a 
health indicator but also as a milestone for development.1 Glob-
ally, maternal deaths have declined from 543,000 cases in 1990 to 
287,000 in 2010. Nevertheless, the reduction in maternal mortal-
ity rate (MMR) lags behind the Millennium Development Goals( 
MDG’s).2 These initiatives have been the cause of some progress-
es in developing countries yet Asia and Africa are still suffering 
from higher MMR.3
Hogan, et al. showed a declining trend of MMR in Iran, changing 
from 101 in 1980, 64 in 1995, and 36 in 2000 to 28 (per 100,000) 
in 2008.4 The State of the World’s Population 2012 reported Iran’s 
MMR to be 21/100,000 live births.5 However, in 2000s in Iran, 
the major causes of pregnancy – related deaths were hemorrhage, 
eclampsia, and infection.6 
Maternal deaths only represent the tip of the iceberg. Apart from 
mortality, the morbidity due to maternal causes additionally poses 
a huge burden on women’s families. There is an excessive need 
to widen the research efforts to address maternal morbidity. Stud-
ies focusing only on maternal mortalities may overlook the most 
common causes of maternal morbidity and the major issues in 
obstetric care.7
The results of national study burden of diseases in 2003 showed 
that DALYs of maternal condition in Iran was 81221.6 In order to 
control and manage maternal conditions and their burden, more 
HI¿FLHQWDQGFRVWHIIHFWLYHSROLFLHVDUHXQGRXEWHGO\UHTXLUHG7R
administer interventions more effectively, the priority-based poli-
cies need regional assessments and comparisons. Evidence-based 
resource allocation at the national and provincial levels leads to 
the provision of a package of services tailored to diverse com-
munities. Consequently, preventive interventions and treatments 
can be applied based on the regional requirements and conditions.
We will introduce and discuss the general framework for the 
study of maternal condition and its burden in Iran, which is a part 
of the National and Sub-national Burden of Diseases8 study from 
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tional and sub-national trends of incidence and burden of maternal 
conditions among Iranian population from 1990 to 2013. The sec-
ond is to estimate national and sub-national inequalities of mater-
nal condition and its burden in Iran from 1990 to 2013.
Materials and Methods
Executive study phases
One of the sub-groups of NASBOD team is the maternal condi-
tion group that incorporates domestic and international members 
and consultants from Tehran University of Medical Sciences, 
Shahid Beheshti University of Medical Sciences. The group will 
conduct a systematic review of the prevalence/incidence of ma-
ternal mortality and morbidities among Iranian population from 
1990 to 2013. Additionally, using the data provided by the mater-
nal mortality surveillance system, mortalities will be calculated 
by province.
'LVHDVHVVHOHFWLRQDQGGH¿QLWLRQV
In this study, similar to the project carried out by World Health 
Organization, the technical committee decided to include only 
three direct obstetric causes of morbidity and mortality: post-par-
tum hemorrhage, post- partum infection, and preeclampsia and 
HFODPSVLD'H¿QLWLRQVRIPDWHUQDOFRQGLWLRQVDQGVHTXHODHZHUH
adopted from GBD 2010 (Table 1). Various heterogeneous data 
sources will be used in the present study that could be categorized 
in two main groups:
A. In general, published, unpublished, and grey literature will be 
used as sources of data in the present study. 
B. Data from National surveys will be utilized accordingly.
A) Published, Unpublished and Grey literature
A systematic search will be carried out for both published and 
unpublished data on maternal mortality and morbidity reported 
between 1985 and 2013. The sources of search will include three 
electronic international (ISI Web of Science, Scopus, Pubmed) and 
three Iranian databases (IranMedex, SID Iran.doc). Hand search-
ing, screening reference lists of the retrieved articles, conference 
abstracts, books, and conference proceedings will be searched as 
ZHOO([SHUWVLQUHVSHFWLYH¿HOGVZLOOEHFRQWDFWHGDQGLQYLWHGWR
collaborate in enriching the available datasets.
Appendix-1 shows search activities in the selected search en-
gines. It presents all MeSH terms, Entry terms and Emtree used for 
searching in PubMed, ISI and Scopus, and all Persian equivalents 
used for searching in IranMedex, SID and Iran.doc.  Population-
based studies at national, provincial, district and community levels, 
reporting the prevalence and/or incidence of maternal conditions, 
will be included in our study. All included papers from January 
1990 to December 2013 will be reviewed. Both English and Per-
sian language papers will be included. Studies that have not re-
ported sampling methods, have used non-representative sampling 
frame, and have selected their participants through non-probability 
sampling methods will be excluded. Research papers will be re-
trieved and will be reviewed by two independent reviewers. 
B) National data
National maternal mortality Surveillance system and death registra-
tion system
The maternal deaths reported by national maternal mortality 
surveillance system will be compared with the maternal deaths 
reported by the death registration system (Mohammadi, et al.) and 
if there would be any difference between the two sources, the in-
completeness of each registration system will be estimated using 
capture recapture methods. 
Other National Data
We will utilize National and Sub-national data of Zij Hayati, 
IMES (Integrated Monitoring and Evaluation Survey 2006), and 
DHS (Demographic and Health Survey 2000).
Hospital data
We will utilize hospital discharge data as an important source of 
data about pregnancy complications. While using this data source, 
we should take into account the problems associated with the se-
lection bias and the variations of patients in terms of access to 
hospital care. More details on hospital registry data are described 
elsewhere.9
Data extraction
Included studies will be reviewed and all needed information 
will be extracted and inserted in data extraction sheet. The data 
collected from registration systems and other national studies, 
which provide the individual level data, will be aggregated and 
inserted in the data extraction sheet. All studies included in our 
UHYLHZZLOOEHFLWHGLQWKH¿QDOUHSRUWDQGLQWKHSXEOLFDWLRQVRI
NASBOD results. If we need more detailed information, we will 
contact the corresponding authors of each study and ask them to 
re-analyze the data. In such a case, we will add the name of au-
thors as our collaborating coauthors. Finally, data extraction sheet 
will be used to summarize the study data by age, sample size, 
prevalence, incidence, mean, standard deviation, standard error 
DQGFRQ¿GHQFHLQWHUYDO7DEOH
 Statistical methods and analysis plans
To overcome the gap caused by the lack of representative data 
at provincial level, in some age groups,, two distinct statistical 
models (includes Spatio-temporal regression model and Bayesian 
multilevel autoregressive model) will be used to estimate mean 
and uncertainty intervals. The data will be entered into the models 
by age, year, and province.  The problem of misalignment due to 
changes in provincial map is going to be addressed by both mod-
els. Using two different models will reduce model dependency of 
the results. 
       
Spatio-temporal regression model
One of the commonly used frameworks to overcome the above-
mentioned limitations is Spatio-temporal regression modeling 
with Conditional Auto Regression (CAR) prior to spatial and 
temporal random effects.10 In spatial framework, observations 
that are closer in space are assumed to be more correlated than 
observations farther away. The structure enables model to “bor-
row information” from neighboring areal units and time periods to 
improve estimates for areas and times with missing values and/or 
small number of observations. In addition, we will employ Spatio-
temporal misalignment modeling to combine incompatible areal 
units between data sources and/or over the years. The model cov-
ers covariates effects, non-linear age trend, and variations in the 
study quality and source of data.11 
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Bayesian Multilevel Autoregressive model
Another advanced method to handle the challenges is Bayesian 
autoregressive multi-level model.12 In this framework, observa-
tions are hierarchically nested at districts, provinces, sub-regions, 
regions, and national levels, respectively. In this hierarchical mod-
el, lower levels borrow information from the higher levels and 
units of each level borrow information from each other depend-
ing on the degree of data availability. The model considers sev-
eral different components including linear time trends, nonlinear 
change over time, covariate effects, non-linearity associated with 
age, heterogeneity of data sources, and age-by-study variability. 
Time-varying covariates at district-level or province-level covari-
ates inform the estimates, if practical.13 
,W LVGLI¿FXOW WRHVWLPDWHDERUWLRQFDXVHGPRUELGLW\EHFDXVH LW
usually happens in places where abortion is illegal and there is no 
precise information about such cases.11 Therefore, it is necessary 
to use adjustment methods to correct the problem of under report-
ing.14 In this study adjustment methods will be used to correct 
under reporting.
All programs will be written in R-statistical packages (version 
3.0.1).
6LQFHWKHSUHVHQWZRUNLVDVHFRQGDU\VWXG\WKHUHDUHQRVSHFL¿F
ethical considerations. However, the publication of the results will 
depend on the permission of the study funders. Likewise, Tehran 
University of Medical Sciences’ Institutional Review Board has 
approved this study in terms of ethical considerations.
Discussion
The study of the burden of maternal conditions as a sub-com-
ponent of a comprehensive project named NASBOD8 has been 
designed to understanding geographic distributions of the selected 
Maternal conditions and  health gaps in this population and their 
inequality between provinces.
Some research studies in the world have estimated the burden of 
maternal condition at Regional  or National level.15–17
 In 2003, the burden of diseases was estimated in Iran based 
on nationally representative data.6 Drawing from the experiences 
learned through the GBD 2010 and the previous national study in 
2003, the National and Sub-national Burden of Diseases (NAS-
%2'VWXG\ZDVGHVLJQHGDVWKH¿UVWHIIRUW WRSURYLGHQDWLRQDO
and sub-national estimates for burden of diseases in Iran over the 
past two decades. 
While studying to estimate the burden of pregnancy morbidity, 
WKH:RUOG+HDOWK2UJDQL]DWLRQIDFHGDVLJQL¿FDQWVKRUWDJHRIGDWD
DQGWKHUHIRUHLWGHWHUPLQHGWKHUDWHVRIMXVW¿YHGLUHFWREVWHWULF
causes of morbidity and mortality, including: post-partum hemor-
rhage, post- partum infection, preeclampsia and eclampsia, ob-
structed labor, and abortion. On the other hand, all types of mor-
bidity do not lead in maternal mortality.14 In the present study, 
only three direct obstetric causes of morbidity and mortality are 
included.
,WLVGLI¿FXOWWRHVWLPDWHWKHEXUGHQRIPRUELGLW\DPDMRUSURE-
lem in estimating pregnancy complications is the disparity of 
data sources that are not comparable. Hence, the World Health 
Organization computes MMR based on systematic reviews and 
expert consensus.14 Unfortunately, in Iran due to the lack of com-
munity-based studies with soundness methodology, we do not 
have reliable estimates of total morbidity caused by acute and 
long-term conditions related to pregnancy and childbirth. Under 
this scenario, national estimate of maternal morbidities is practi-
cally incomplete and relying only on national Maternal Mortality 
and Morbidity statistics hides the differences between regions and 
population subgroups (age, region geography, and race). In this 
study, the data collected from different sources are used to esti-
mate the incidence and prevalence of Maternal morbidity via the 
Cause / sub-cause Compatibility with clinical sequela Sequela name Description
ICD-10 Cods for maternal 
morbidity conditions 
O00-O99
Maternal 
hemorrhage Anemia, mild
This person feels slightly tired and weak at times, 
but this does not interfere with normal daily 
activities
O20, O44–O46, O67, O72
Maternal sepsis
Abdomino-
pelvic problem, 
mild
This person has some pain in the belly that causes 
nausea but does not interfere with daily activities. O85–O86
Hypertensive 
disorders of 
pregnancy
Compatible with  
temporary renal 
complications
Chronic kidney 
disease (stage 
IV)
This person feels tired easily, has nausea, reduced 
DSSHWLWHDQGGLI¿FXOW\VOHHSLQJ O10–O16
Abortion Acute short duration disability
Abdominopelvic 
problem, mild
This person has some pain in the belly that causes 
nausea but does not interfere with daily activities.
aEach piece of this table may be updated during the study.
Table 1. &DVHDQGVHTXHODHGH¿QLWLRQVIRU0DWHUQDO&RQGLWLRQV
Table 2.
General information
Study name, citation, city (where the study was conducted), publication year, study year, journal, characteristics and contact 
address of corresponding author. Population characteristics: Age (age groups as, 10–14,15–19, 20–24, 25–29, 30–34, 35–39, 
40–44, 45–49)
Methodological 
information
Study design, data source, scope of study (urban, rural or Urban-rural), coverage of the study (national, provincial, district, and 
community level), measurement tools, sample size, sampling method, sample weight, response rate.
Study outcomes Proportion of cases to the total number of population included in the study (prevalence), incidence, mortality; all presented ZLWKXQFHUWDLQW\LQWHUYDODQGVWUDWL¿HGE\DJHJURXSV
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systematic review methodology.
 The variety of sources and methods used to calculate maternal 
mortality rate and the absence of national data in many countries 
DUHWKHPDLQSUREOHPVLGHQWL¿HGE\WKHJOREDOVXUYHLOODQFHV\V-
tem of maternal mortality rate.8 Consequently, in 2000, the World 
Health Organization used a regression model to estimate MMR 
in 62 countries without national maternal mortality data.18 The 
underestimation of MMR is not only due to sampling errors, but 
it is also caused by differences in the precision of reporting and 
FODVVL¿FDWLRQV\VWHPVZLWKLQGLIIHUHQWUHJLRQVDQGSRSXODWLRQV13 
In order to control consistency, it seems important to compare es-
timates from various sources with the estimates produced by the 
multiple regression model.9,19
7RPHDVXUHKHDOWK LQHTXDOLWLHV LW LV HVVHQWLDO WR¿QGRXWKRZ
these differences are distributed among the populations and also 
to determine whether the distributions are socially plausible or 
not. Studies on health inequalities are mainly focused on inequali-
ties in non-biological factors such as gender, nationality, race 
and income.16 Currently, novel methodologies and different data 
sources allow more precise estimates of maternal mortality and 
morbidity,4 and their inequality between provinces.
The key differences of this study with the previous study in 
Iran are including scope and coverage of the study, data sources, 
and methods and analyses.8 Given the availability of high quality 
sub-national data and updated analytic methods, the NASBOD 
study will provide a chance to assess both in-depth sub-national 
estimates and trends in epidemiological metrics of diseases over 
the period 1990 – 2013 in Iran. It provides a clearer picture for 
GLVHDVHPDQDJHPHQWDQGHI¿FLHQWLQWHUYHQWLRQVDQGFDQKHOSWKH
health system to allocate services effectively and cover the related 
ethical issues.
The limitations of this study are as follows: First, we will use 
various sources of data, and there may be heterogeneity between 
data sources, which will be managed by methodological strate-
gies.  Second, there may be limited access to the full texts of cer-
tain published or unpublished epidemiological studies, as one of 
the main data sources. Third, due to absence of community-based 
VWXGLHVWKHUHDUHQRWVXI¿FLHQWGDWDRQPDWHUQDOFRQGLWLRQV)LQDO-
ly, for estimating abortion-caused morbidity, it usually happens in 
places where abortion is illegal and there is no precise information 
about such cases, in this study adjustment methods will be used to 
correct under reporting.
7KLVVWXG\ LV WKH¿UVWFRPSUHKHQVLYHV\VWHPDWLFVWXG\DVVHVV-
ing the prevalence and burden of maternal conditions in Iran at 
QDWLRQDODQGVXEQDWLRQDOOHYHOV6LQFHWKH¿QGLQJVZLOOEHXVHG
to identify distributions and inequalities of maternal conditions 
in our country, they can play an important role in directing future 
policies and planning cost-effective strategies .
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“Hypertension, Pregnancy-Induced”OR”Pregnancy-Induced Hypertension” OR”Pregnancy Induced Hypertension” OR”Hypertensions, Pregnancy Induced” 
OR”Induced Hypertension, Pregnancy” OR”Induced Hypertensions, Pregnancy” OR”Gestational Hypertension” OR”Hypertension, Gestational” OR “Transient 
Hypertension, Pregnancy” OR”Hypertension, Pregnancy Transient” OR”Pregnancy Transient Hypertension”
HELLP Syndrome
“HELLP Syndrome”OR”Syndrome, HELLP” OR”Hemolysis, Elevated Liver Enzymes, Lowered Platelets”
Placenta Accreta
“Placenta Accreta”OR”Accreta, Placenta”OR “Placenta Increta”OR “Increta, Placenta”OR “Placenta Percreta” OR”Percreta, Placenta”
Postpartum Hemorrhage
“Postpartum Hemorrhage”OR”Hemorrhage, Postpartum”OR “Immediate Postpartum Hemorrhage”OR “Hemorrhage, Immediate Postpartum”OR”Postpartum 
Hemorrhage, Immediate”OR “Delayed Postpartum Hemorrhage”OR “Hemorrhage, Delayed Postpartum”OR “Postpartum Hemorrhage, Delayed”
Uterine Inversion
»Uterine Inversion«OR”Inversion, Uterine” OR”Inversion of Uterus” OR “Uterus Inversion”
Uterine Rupture
“Uterine Rupture”OR”Rupture, Uterine” OR”Ruptures, Uterine” OR”Uterine Ruptures”
Vasa Previa
“Previa, Vasa”OR “Previas, Vasa”OR “Vasa Previas”OR “Vasa Praevia”OR “Praevia, Vasa”OR”Praevias, Vasa”OR “Vasa Praevias”
Search engine Search activity
PubMed DOO0H6+WHUPVZLOOEHVHDUFKHGLQ³$OO¿HOGV´
ISI (Web of Science) all MeSH terms and Entry terms will be searched in “Topic”
Scopus all MeSH terms, Entry terms and Emtrees will be searched in “Title, Abstract, Keyword”
IranMedex and SID (English) all MeSH terms and Entry terms will be searched in “Title, Abstract, Keyword”
IranMedex and SID (Persian) all Persian equivalents will be searched in “Title, Abstract, Keyword”
Irandoc (Persian) DOO3HUVLDQHTXLYDOHQWVZLOOEHVHDUFKHGLQ³$OO¿HOGV´
$OOWKHNH\ZRUGVZLOOEHFRPELQHGE\³25´RSHUDWRULQWKHVHDUFKHQJLQHV/LPLWDWLRQVRIVHDUFK*HRJUDSKLFDO/LPLWDWLRQLVGH¿QHGE\WKHIROORZLQJSKUDVH
>,UDQ253HUVLD25³,5,UDQ´25³,5,UDQ´@LQDOOGDWDEDVHVDQGZLOOEHDGGHGWRWKHVHDUFKE\³$1'´RSHUDWRU7LPH/LPLWDWLRQLVIURPWRLQ
PubMed and Scopus and from 1990 to 2012 in ISI. Only the human studies are included in the study.
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Puerperal Infection
“Puerperal Infection”OR”Infection, Puerperal”OR “Infections, Puerperal”OR “Puerperal Infections”
Abortion, Spontaneous
»Abortion, Spontaneous”OR”Abortions, Spontaneous” OR”Spontaneous Abortions” OR”Miscarriage” OR”Miscarriages” OR”Spontaneous Abortion” 
OR”Abortion, Tubal” OR”Abortions, Tubal” OR”Tubal Abortion” OR”Tubal Abortions«
Abortion, Habitual 
»Abortion, Habitual”OR”Abortions, Habitual” OR”Habitual Abortion” OR “Habitual Abortions” OR”Miscarriage, Recurrent” OR”Miscarriages, Recurrent” 
OR”Recurrent Miscarriage” OR”Recurrent Miscarriages” OR”Abortion, Recurrent” OR”Abortions, Recurrent” OR”Recurrent Abortion” OR”Recurrent Abortions«
Abortion, Incomplete
»Abortion, Incomplete”OR”Abortions, Incomplete” OR”Incomplete Abortion” OR”Incomplete Abortions«
Abortion, Missed
»Abortion, Missed”OR”Abortions, Missed” OR”Missed Abortion” OR”Missed Abortions«
Abortion, Septic
»Abortion, Septic”OR”Abortions, Septic” OR”Septic Abortions” OR”Septic Abortion«
Abortion, Threatened
»Abortion, Threatened”OR”Abortions, Threatened” OR”Threatened Abortion” OR”Threatened Abortions«
Embryo Loss
»Embryo Loss”OR”Embryo Disintegration” OR”Disintegration of Embryo” OR”Blastocyst Disintegration” OR”Disintegration, Blastocyst” OR”Disintegration of 
Blastocyst” OR”Embryo Resorption” OR”Resorption, Embryo” OR”Embryo Death” OR”Death, Embryo” OR”Embryo Deaths«
Abruptio Placentae Abortion, Missed
»Abruptio Placentae Abortion, Missed”OR”Abortions, Missed”OR”Missed Abortion”OR”Missed Abortions«
Abortion, Induced
»Abortion, Induced” OR”Induced Abortion” OR”Abortions, Induced” OR”Induced Abortions” OR”Abortion (Induced)” OR”Abortions (Induced)” OR”Abortion 
Rate” OR “Abortion Rates” OR”Rate, Abortion” OR”Rates, Abortion” OR “Abortion Techniques” OR”Abortion Technique” OR”Technique, Abortion” OR 
“Techniques, Abortion” OR”Abortion Technics” OR”Abortion Technic” OR”Technic, Abortion” OR”Technics, Abortion” OR”Abortion, Drug-Induced” 
OR”Abortion, Drug Induced” OR”Abortions, Drug-Induced” OR”Drug-Induced Abortion” OR”Drug-Induced Abortions” OR”Previous Abortion” OR “Abortion, 
Previous” OR”Abortions, Previous” OR”Previous Abortions” OR”Abortion History” OR”Abortion Histories” OR”Histories, Abortion” OR”History, Abortion” 
OR”Abortion, Saline-Solution” OR”Abortion, Saline Solution” OR”Abortions, Saline-Solution” OR”Saline-Solution Abortion” OR”Saline-Solution Abortions” 
OR”Abortion, Soap-Solution” OR”Abortion, Soap Solution” OR”Abortions, Soap-Solution” OR “Soap-Solution Abortion” OR”Soap-Solution Abortions” 
OR”Anti-Abortion Groups” OR”Anti Abortion Groups” OR”Anti-Abortion Group” OR”Group, Anti-Abortion” OR”Groups, Anti-Abortion” OR “Embryotomy” 
OR”Embryotomies” OR”Fertility Control, Postconception” OR “Postconception Fertility Control”OR “Abortion Failure” OR “Abortion Failures” OR “Failure, 
Abortion” OR “Failures, Abortion” OR  “Abortion, Rivanol” OR “Abortions, Rivanol” OR “Rivanol Abortion” OR “Rivanol Abortions«
Abruptio Placentae
»Abruptio Placentae”OR”Placental Abruption”OR “Abruption, Placental”OR “Abruptions, Placental”OR “Placental Abruptions«
Placenta Previa
“Placenta Praevia”
